BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CFR Pharmaceuticals Investing $27 Million in Uman Pharma Inc.


11/10/2011 11:37:26 AM

CANDIAC, QC, Nov. 10, 2011 /PRNewswire/ - Uman Pharma Inc., a Canadian privately owned generic pharmaceutical company is pleased to announce the conclusion of a strategic partnership with CFR Pharmaceuticals S. A. (CFR) of Santiago, Chile. As part of this transaction CFR acquired a 50.79% shareholding in Uman through a capital investment of C$27.0 million. CFR is a publicly traded (CFR) leading Latin American pharmaceutical company with operations in Latin America and other emerging markets.

Sylvain Duvernay, Uman Pharma's Chief Executive Officer said: "Among other corporate purposes, CFR's injection of funds will allow Uman to increase substantially the number of specialized oncology products to be developed and manufactured in Candiac, Canada, for commercialization worldwide."

"By combining our expertise with CFR's sales and marketing team, Uman has increased its potential to serve the regulated markets for valuable medications. This association will also open the Emerging Markets for Uman's products."

About Uman Pharma

Uman Pharma is a global pharmaceutical company based in Candiac, on the south shore of Montreal, Canada. Its strengths lie in the development and manufacturing of cytotoxic and high potent sterile injectable and solid dosage products for the oncology market. Uman's portfolio of products includes proprietary and generic formulations, backed by an experienced and professional team and GMP manufacturing facilities (11,700m2) certified for Canada and Europe and in the process to be approved by the United States FDA.

Please visit www.umanpharma.com for more information.

About CFR Pharmaceuticals

CFR Pharmaceuticals S.A. is a leading Latin American pharmaceutical company with operations in 15 countries in Latin America (mainly Chile, Peru, Argentina and Colombia), and other emerging markets. Its business model is focused on the development, manufacture and commercialization of off-patent and locally unpatented branded specialty pharmaceutical products. The company manages its operations along several business segments.

Please visit www.cfr-corp.com for more information.

SOURCE Uman Pharma Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES